Rchr
J-GLOBAL ID：201701010106640994   Update date: Mar. 04, 2024

Miyabe Katsuyuki

ミヤベ カツユキ | Miyabe Katsuyuki
Affiliation and department：
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital Gastroenterology

About Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital Gastroenterology


Job title： Deputy Director
Research keywords  (5)： Metabolome ,  IgG4-related disease ,  pancreatic tumor ,  microbiome ,  cholangiocarcinoma
Research theme for competitive and other funds  (10)：
  • 2022 - 2025 Clarifying beneficial effects of statins to improve survival of patients with cholangiocarcinoma using the analysis of bile metabolome
  • 2019 - 2022 Identification of sentization markers and elucidation of drug resistance mechanism for a CK2 inhibitor on cholangiocarcinoma
  • 2016 - 2020 Identification of sentization markers and elucidation of drug resistance mechanism for FGFR inhibitors on cholangiocarcinoma
  • 2016 - 2018 The role of the biliary and gut microbiome in the progression of cholangiocarcinoma and primary sclerosing cholangitis
  • 2014 - 2018 The establishment of novel endoscopic diagnostic method and biomarker for cholangiocarcinoma by fluorescence in situ hybridization
Show all
Papers (144)：
  • Tadashi Toyohara, Michihiro Yoshida, Katsuyuki Miyabe, Kazuki Hayashi, Itaru Naitoh, Hiromu Kondo, Yasuki Hori, Akihisa Kato, Kenta Kachi, Go Asano, et al. Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms. Cancer science. 2023. 114. 12. 4571-4582
  • Michihiro Yoshida, Hiroshi Yukawa, Kazuki Hayashi, Itaru Naitoh, Katsuyuki Miyabe, Yasuki Hori, Makoto Natsume, Naruomi Jinno, Akihisa Kato, Kenta Kachi, et al. Clinical impact of bile-derived exosomal miRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers. Cancer science. 2022. 114. 1. 295-305
  • Akihisa Kato, Itaru Naitoh, Aya Naiki-Ito, Kazuki Hayashi, Fumihiro Okumura, Yasuaki Fujita, Hitoshi Sano, Yuji Nishi, Katsuyuki Miyabe, Tadahisa Inoue, et al. Class III β-Tubulin Expression Is of Value in Selecting nab-Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer. Pancreas. 2022. 51. 4. 372-379
  • Akihisa Kato, Makoto Natsume, Michihiro Yoshida, Katsuyuki Miyabe, Yasuki Hori, Itaru Naitoh, Kazuki Hayashi. Endoscopic tapered sheath-assisted removal of a proximally migrated pancreatic stent. Endoscopy. 2022
  • Go Asano, Katsuyuki Miyabe, Hiroyuki Kato, Michihiro Yoshida, Takeshi Sawada, Yasuyuki Okamoto, Hidenori Sahashi, Naoki Atsuta, Kenta Kachi, Akihisa Kato, et al. Relevance of gene mutations and methylation to the growth of pancreatic intraductal papillary mucinous neoplasms based on pyrosequencing. Scientific reports. 2022. 12. 1. 419-419
ｍore...
MISC (18)：
  • 豊原祥資, 吉田道弘, 宮部勝之, 鬼頭佑輔, 佐橋秀典, 浅野剛, 加地謙太, 加藤晃久, 堀寧, 内藤格, et al. 膵神経内分泌腫瘍におけるオートタキシンの新規Theranostics targetとしての可能性. 膵臓(Web). 2023. 38. 3
  • 豊原祥資, 吉田道弘, 宮部勝之, 鬼頭佑輔, 安達明央, 久野佳世子, 佐橋秀典, 加地謙太, 加藤晃久, 堀寧, et al. Autotaxin as a novel potential target of ’Theranostics’ for pancreatic neuroendocrine neoplasms. 日本癌学会学術総会抄録集(Web). 2023. 82nd
  • 松尾 洋一, 林 香月, 上田 悟郎, 加藤 知克, 青山 佳永, 大見 関, 林 祐一, 今藤 裕之, 齊藤 健太, 坪井 謙, et al. 術前診断に難渋した膵海綿状血管腫の1例. 膵臓. 2021. 36. 4. 266-273
  • 浅野剛, 加地謙太, 加藤晃久, 神野成臣, 夏目まこと, 堀寧, 吉田道弘, 宮部勝之, 内藤格, 林香月. 経乳頭的胆嚢ステント留置術における改良版ガイドワイヤーの有用性. 胆道(Web). 2019. 33. 3
  • 宮部勝之, 林香月, 内藤格. 十二指腸乳頭腫瘍に対する内視鏡的乳頭切除術穿孔時におけるOTSC縫縮法の有用性. 胆道(Web). 2019. 33. 3
ｍore...
Books (1)：
  • 消化器診療
    医学書院 2015
Lectures and oral presentations  (11)：
  • The role of the biliary and gut microbiome in the progression of cholangiocarcinoma and primary sclerosing cholangitis
    (ACG 2019 Annual Scientific Meeting 2019)
  • 胆管癌治療における新規Casein Kinase 2阻害剤有用性の基礎的検討
    (第60回日本消化器病学会大会 2018)
  • Preclinical in vitro and in vivo evidence of an antitumor effect of CX-4945, a CK2 inhibitor, in cholangiocarcinoma
    (The Cholangiocarcinoma Foundation Annual Conference 2016 2017)
  • The casein kinase II inhibitor CX-4945 has an additive effect with gemcitabine and cisplatin on cholangiocarcinoma xenografts
    (Digestive Disease Week 2016 2016)
  • Fibroblast Growth Factor Receptor (FGFR) Gene Family Aberrations in Cholangiocarcinoma.
    (The Cholangiocarcinoma Foundation Annual Conference 2016 2016)
ｍore...
Education (2)：
  • 2009 - 2013 Nagoya City University Graduate School of Medical Sciences Department of Gastroenterology and Metabolism
  • 1991 - 1997 Jichi Medical Univerisity Medicine Medicine
Professional career (1)：
  • 医学博士 (名古屋市立大学大学院)
Work history (13)：
  • 2022/04 - 現在 Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital Department of Gastroenterology Director
  • 2019/04 - 現在 Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital Department of Gastroenterology Deputy Director
  • 2019/01 - 2019/03 Nagoya City University Graduate School of Medical Sciences Department of Gastroenterology and Metabolism Lecturer
  • 2017/07 - 2018/12 Nagoya City University Graduate School of Medical Sciences Department of Gastroenterology and Metabolism Assistant Professor
  • 2016/06 - 2017/06 Mayo Clinic, Rochester, Minnesota Division of Gastroenterology and Hepatology Research Fellow
Show all
Association Membership(s) (7)：
日本臨床腫瘍学会 ,  JAPAN PANCREAS SOCIETY ,  THE JAPAN SOCIETY OF HEPATOLOGY ,  JAPAN BILIARY ASSOCIATION ,  JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY ,  JAPANESE SOCIETY OF GASTROENTEROLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM